Your present position:
Home >


Alprostadil is produced endogenously and causes vasodilation by means of a direct effect on vascular and ductus arteriosus (DA) smooth muscle, preventing or reversing the functional closure of the DA that occurs shortly after birth. This results in increased pulmonary or systemic blood flow in infants. In infants, it is used for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. In adults, it is used for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology.
Packing specification:
Dosage form

Product details

The product name 前列地尔 Report progress Registration Completed (DMF No.)
English names Alprostadil indications Patent ductus arteriosus, Sexual dysfunction
CAS no. 745-65-3 place of origin Taiwan
IDL no./Registration no. Y20170001460 Dosage form API
Chemical name 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid